Digging into March-In: Appealing Concept for Some, But Anathema to Others
Fresh Look at History and Current Issues
Marching in to seize the rights to a seemingly miraculous therapy that has been relegated to a dark shelf in some mammoth or not-so-mammoth biomedical firm has some appeal to frustrated patients and others deeply concerned about saving lives.
The reality is somewhat different.
A long look at the situation surfaced this morning in Washington, D.C., which…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.